Thursday, October 28, 2010 Local traders charged in alleged $30 million fraud
A Hopkinton man was arrested this morning and charged with allegedly defrauding more than 1,000 investors of more than $30 million, the US Department of Justice said today. Teradyne shares down on 4Q outlook
Shares of chip company Teradyne Inc. tumbled today after its outlook for the fourth quarter widely missed Wall Street's expectations. MooBella sees airports as ideal ice cream venue
MooBella Inc. sees airports as ideal venues for its high-tech ice cream machines. Mass. consumer confidence is up a bit
Consumer confidence in Massachusetts rose slightly over the past three months as views of the future became more optimistic, a Boston consulting firm reported today. First Wind delays IPO
First Wind Holdings Inc., a Boston-based developer of wind farms, said today that it will not move forward with its planned initial public offering of stock. Sanofi refuses to raise $18.5b offer for Genzyme
The top executive of Sanofi Aventis SA, refusing to budge from his $18.5 billion bid for Genzyme Corp., this morning unleashed a withering critique of the Cambridge biotechnology company's contention that is worth about $89 a share. BU will break ground on student residence
Mayor Thomas M. Menino is scheduled to join Boston University president Robert Brown and Boston University School of Medicine officials for a ground-breaking ceremony of a new graduate student residence this afternoon, Menino's office said. Raytheon profit grows, raises 2010 profit outlook
Strong performance and cost cuts helped lift third quarter profits for Raytheon Co. by nearly 49 percent. Green Mountain to sell auto insurance in Mass.
Green Mountain Insurance Company will begin selling auto insurance in Massachusetts on Dec. 1, the state's Division of Insurance said today. Idenix has a new CEO
Idenix Pharmaceuticals Inc. said today that Ronald C. Renaud, Jr. has been elected as president, chief executive and a member of the board of directors of the Cambridge-based company. Boston Scientific agrees to sell unit for up to $1.5b
Boston Scientific Corp., the Natick-based medical device company, said it has agreed to sell its neurovascular business to Stryker Corp. for $1.5 billion as part of Boston Scientific's strategy to focus on its core business. IRobot 3Q profit rises as robot demand rises
Robot maker iRobot Corp. said its third-quarter profit more than doubled as revenue climbed from robots used in homes and by the government. The company also raised its outlook for the year, and iRobot shares climbed in after-hours trading. Wednesday, October 27, 2010 Two Boston-area men charged with hiding UBS investments
The US Attorney in Boston has charged two Boston-area men with concealing their investments with Swiss banking giant UBS from the federal government and from the Internal Revenue Service. City aims to put price tag on Filene's blight
Boston officials said today they will seek to calculate the economic losses caused by the stalled Filene's redevelopment as part of a review that could lead to permanent revocation of the project's approvals. | 
No comments:
Post a Comment